Antioxidant evaluation of heterocyclic compounds by cytokinesis-block micronucleus assay

Mini Rev Med Chem. 2013 Mar;13(3):431-8.

Abstract

This article summarizes the results of using cytokinesis-block micronucleus (CBMN) assay to evaluate the antioxidant potential of heterocyclic compounds. Most studies were carried out with naturally occurring heterocyclic compounds such as plant polyphenols: flavonoids, xanthones, coumarins, and ellagitannins, or plant derived products (juices, extracts, supplements) rich in bioactive heterocyclic compounds. There are also some studies dealing with synthetic heterocyclic antioxidants. CBMN assay is an in vitro study that has been used to evaluate antioxidant and protective effects of heterocyclic compounds on induced chromosome aberration in human lymphocytes.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antioxidants / pharmacology*
  • Cytokinesis / drug effects*
  • Heterocyclic Compounds / pharmacology*
  • Humans
  • Micronucleus Tests*

Substances

  • Antioxidants
  • Heterocyclic Compounds